Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

While programmed cell death 1 (PD-1) inhibitors have shown clear anti-tumor efficacy in several solid tumors, prior results in men with metastatic castration resistant prostate cancer (mCRPC) showed no evidence of activity. Here we report unexpected antitumor activity seen in mCRPC patients treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Graff, Julie N., Alumkal, Joshi J., Drake, Charles G., Thomas, George V., Redmond, William L., Farhad, Mohammad, Cetnar, Jeremy P., Ey, Frederick S., Bergan, Raymond C., Slottke, Rachel, Beer, Tomasz M.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper: Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288150/
https://ncbi.nlm.nih.gov/pubmed/27429197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados